US Stock MarketDetailed Quotes

ARQT Arcutis Biotherapeutics

Watchlist
  • 14.585
  • +0.205+1.43%
Trading Mar 11 10:01 ET
1.73BMarket Cap-12.57P/E (TTM)

Arcutis Biotherapeutics Key Stats

Arcutis Biotherapeutics Q4 2024 Earnings Date

Currency:USDFeb 25, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
60.52M
71.36M
+10.84M
Beat Est.
+347.41%
+427.58%
+17.92%
EPS
-0.24
-0.09
+0.15
Beat Est.
+66.22%
+87.50%
+62.99%
Strong Buy

Mar 11, 2025

Arcutis Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 72.795M--
--2025/Q1-- / 65.135M--
Feb 25, 20252024/Q471.360M / 60.517M--
Nov 6, 20242024/Q344.755M / 37.340M--
Aug 14, 20242024/Q230.858M / 29.080M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 72.795M--
--2025/Q1-- / 65.135M--
Feb 25, 20252024/Q471.360M / 60.517M--
Nov 6, 20242024/Q344.755M / 37.340M--
Aug 14, 20242024/Q230.858M / 29.080M--

Unlock Free Earnings Estimates

Arcutis Biotherapeutics Earnings Reports

Read more

Trending Stocks

Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
As China's 'two sessions' commence: How will Chinese stocks perform?
🎙️Discussion 1. With the government's emphasis on technological innovation and sustainability, which industry sectors do you believe hold t Show More